Sunshield Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve In furtherance to our intimation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunshield Chemicals has informed BSE that its Board meeting on July 31, 2025 will consider withdrawing the Draft Letter of Offer originally filed with SEBI on September 30, 2024, for a rights issue of up to ₹200 crore (initially approved on August 9, 2024). The company wants to refile the rights issue under SEBI's Amended Rights Issue Regulations that came into effect on April 7, 2025, which simplify and speed up the process. The company clarified that no additional equity shares are being offered—this is the same rights issue being re-approved under the new framework. The Board will also review unaudited financial results for Q1 FY26 (quarter ended June 30, 2025).
Existing shareholders will get the opportunity to subscribe to the rights issue under a simpler, faster SEBI process, but no new dilution beyond the originally approved ₹200 crore is being proposed. The stock may see mild movement as the timing of the fresh rights issue nears.